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Abstract

Results

Homologous recombination is a mechanism conducted to exchange
nucleotides between two similar sequences, which allows researchers to
knock out and add genetic sequences of their interest in vaccinia virus
(VACV). In this study, a Western Reserve VACV strain with inserted genes
encoding Red Florescence Protein (RFP) and Green Florescence Protein
(GFP), will be targeted and replaced with the Thymidine Kinase gene, J2R
as well as C11 gene, respectively. This will set the foundation for continual
removal of genes as well as additions to make a virus that will more
effectively target cancer cells without affecting healthy cells. To conduct
this experiment, the J2R gene was constructed via overlapping PCR and
shared homology with the Western Reserve strain allowing for the
homologous recombination to occur. HeLa cells are then infected and
transfected with the VACV and the J2R overlapping PCR fragment,
respectively. The transfection of the overlapping J2R PCR fragment into the
infected HeLa cells will allow the virus to recombine. The infected cells are
then collected and used to infect BS-C-1 cells, which allowed formation of
plaques. The green (GFP) plaques without RFP are to be collected and
undergo several rounds of purification. Upon purification, the DNA will be
extracted using an SQ Blood Kit and enhanced via PCR. To confirm the
virus recombined appropriately, the DNA will be sent out for sequencing
and the procedure will be repeated for the replacement of GFP with C11
overlapping PCR fragment. Upon successful recombinant virus
construction, the virus will undergo additional knockouts as well as
additions that will allow the virus to target cancerous cells more effectively.
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Figure 1: Schematics of Red Florescence Protein integrated in VACV and Expected
Recombination with Overlapping Primer.
A. Schematic contains the current schematic of the Western Reserve Vaccinia Virus with
the Red Florescent protein integrated along with a G8R promoter. The primers are
included, two of which were design for overlapping PCR.
B. The expected recombination of the vaccinia virus with the overlapping PCR segment.
This then allows the J2R upstream and downstream green segments to rejoin.
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B. Expected Recombination Map of DNA sequence of J2R gene with the
overlapping PCR primers.

J2R PCR
Figure 2: Screening and Conformation of
Overlapping PCR Fragment using Gel
Electrophoresis
The electrophoresis gel demonstrates the correct
fragment from the overlapping PCR reaction.
This will be used transfect the HeLa cells.
Figure 3: DNA sequences of the initial Vaccinia Virus with RFP and the
expected recombination map of the J2R gene.

Conclusion and Future Research
• After the removal of the Red Florescent Protein from the Western Reserve Vaccinia Virus, the procedure will be repeated with the removal of Green
Florescent Protein using the same method used in this experiment.
• This research is setting the foundation for additional gene knockouts as well as gene implementations that will allow the virus o more specifically target
cancer cells.
• The genes that will be targeted include viral immunoregulating genes of Vaccinia Virus including Virus Growth Factor (VGF) and K1L gene.
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